Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis

Urology

Volumn 60, Issue 5, 2002, Pages 869-874

  Madersbacher, Stephan ^a   Schatzl, Georg ^a   Bieglmayer, Christian ^a   Reiter, Werner J ^a   Gassner, Christa ^a   Berger, Peter ^b   Zidek, Thomas ^a   Marberger, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; ENDOCRINOLOGY; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INTERMETHOD COMPARISON; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; SCORING SYSTEM; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL; TRANSURETHRAL RESECTION; URETHRA;

AGED; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES; TESTOSTERONE;

EID: 0036844762     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01893-9     Document Type: Article

References (18)

1. Ekman P. The prostate as an endocrine organ androgens and estrogens . Prostate. 10:(suppl):2000;14-18.
2. Hsing A.W. Hormones and prostate cancer what's next . Epidemiol Rev. 23:2001;42-58.
3. Gray A., Feldman H.A., McKinlay J.B., et al. Age, disease and changing sex hormone levels in middle aged men results of the Massachusetts Male Aging Study . J Clin Endocrinol Metab. 73:1991;1016-1025.
4. Schatzl G., Brssner C., Schmid S., et al. Endocrine status in elderly men with lower urinary tract symptoms correlation of age, hormonal status and LUTS function . Urology. 55:2000;397-402.
5. Harper M.E., Pierrepoint C.G., Griffiths K. Carcinoma of the prostate relationship of pretreatment hormone levels to survival . Eur J Cancer Clin Oncol. 20:1984;477-482.
6. Nomura A., Heilbrun L.K., Stemmermann G.N., et al. Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res. 48:1988;3515-3517.
7. Andersson S.O., Adami H.O., Bergstrm R., et al. Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer - a population-based case-control study. Br J Cancer. 68:1993;97-102.
8. Hsing A.W., Comstock G.W. Serological precursors of cancer serum hormones and risk of subsequent prostate cancer . Cancer Epidemiol Biomarkers Prev. 2:1993;27-32.
9. Gann P.H., Hennekens C.H., Ma J., et al. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst. 88:1996;1118-1126.
10. Slater S., Oliver R.T. Testosterone its role in development of prostate cancer and potential risk from use as hormone replacement therapy . Drugs Aging. 17:2000;431-439.
11. Schatzl G., Madersbacher S., Thrridl T., et al. High grade prostate cancer is associated with low serum testosterone levels. Prostate. 47:2001;52-58.
12. Meikle A.W., Stanish W.M. Familial prostatic cancer risk and low testosterone. J Clin Endocrinol Metab. 54:1982;1104-1108.
13. Vermeulen A., Verdonck L., Kaufmann J. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 10:1999;3666-3672.
14. Griffiths K., Eaton C.L., Harper M.E., et al. Steroid hor-mones and the pathogenesis of benign prostatic hyperplasia. Eur Urol. 20:(suppl 1):1991;68-77.
15. Trklmez K., Bozlu M., Sarcia K., et al. Effects of the transurethral prostate resection and transurethral laser prostatectomy on plasma hormone levels. Urol Int. 61:1998;162-167.
16. Sasagawa I., Nadaka H., Suzuki H., et al. Effect of transurethral resection of prostate on plasma levels in benign prostatic hyperplasia. Br J Urol. 72:1993;611-614.
17. Miller L., Partin A., Chan D., et al. Influence of radical prostatectomy on serum hormone levels. J Urol. 160:1998;449-453.
18. Phadke M.A., Vanage G.R., Sheth A.R. Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection. Prostate. 10:1987;115-122.